{
  "name" : "dacemirror.sci-hub.se_journal-article_f8c68af329111416f3ce4bb5c9f0044d_marola2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Management of venous ulcers: State of the art",
    "authors" : [ "Silvia Marola", "Alessia Ferrarese", "Mario Solej", "Stefano Enrico", "Mario Nano", "Valter Martino" ],
    "emails" : [ "silviamarola@gmail.com,", "alessia.ferrarese@gmail.com,", "osolej@gmail.com,", "stefano_e@libero.it,", "mario.nano@unito.it,", "no.md@gmail.com", "alessia.ferrarese@gmail.com" ],
    "sections" : [ {
      "heading" : "Accepted Manuscript",
      "text" : "Management of venous ulcers: State of the art Silvia Marola, Assistant of General Surgery at General Surgery Section, Alessia Ferrarese, MD, Assistant of General Surgery at General Surgery Section, Mario Solej, Assistant of General Surgery at General Surgery Section, Stefano Enrico, General Surgeon at General Surgery Section, Mario Nano, Ordinary Professor of General Surgery, Valter Martino, General Surgeon at General Surgery Section\nPII: S1743-9191(16)30173-X DOI: 10.1016/j.ijsu.2016.06.015 Reference: IJSU 2855\nTo appear in: International Journal of Surgery\nPlease cite this article as: Marola S, Ferrarese A, Solej M, Enrico S, Nano M, Martino V, Management of venous ulcers: State of the art, International Journal of Surgery (2016), doi: 10.1016/j.ijsu.2016.06.015.\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nM AN\nUS CR\nIP T\nAC CE\nPT ED"
    }, {
      "heading" : "MANAGEMENT OF VENOUS ULCERS: STATE OF THE ART",
      "text" : "Running title: Venous ulcers Silvia Marola, Alessia Ferrarese, Mario Solej, Stefano Enrico, Mario Nano, Valter Martino\nUniversity of Turin - Department of Oncology – School of Medicine –Teaching Hospital “San Luigi Gonzaga” – Section of General Surgery - Orbassano – Turin, Italy\nE-mail: MS: silviamarola@gmail.com, AF: alessia.ferrarese@gmail.com, MS: mariosolej@gmail.com, SE: stefano_e@libero.it, MN: mario.nano@unito.it, VM: valtermartino.md@gmail.com\nSM: Assistant of General Surgery at General Surgery Section – Orbassano- University of Torino AF: Assistant of General Surgery at General Surgery Section – Orbassano- University of Torino MS: Assistant of General Surgery at General Surgery Section – Orbassano- University of Torino SE: General Surgeon at General Surgery Section – Orbassano- University of Torino MN: Ordinary Professor of General Surgery - University of Torino VM: General Surgeon at General Surgery Section – Orbassano- University of Torino\nCorrespondence to: Alessia Ferrarese MD, Department of Oncology, University of Turin, Section of General Surgery, San Luigi Gonzaga Teaching Hospital, Regione Gonzole 10, 10043 Orbassano – Turin (Italy), Email alessia.ferrarese@gmail.com\nThe authors declare that they have no conflict of interest or financial support\nM AN\nUS CR\nIP T\nAC CE\nPT ED"
    }, {
      "heading" : "Abstract",
      "text" : "Venous ulceration is a complex and serious problem that affects 1–2% of the global elderly population (>65 years), and its incidence is constantly increasing. The population group with higher risk of development of venous ulceration is the elderly. These lesions have a significant negative impact on patients’ quality of life. Our aim was to analyze the state of the art, starting with the medical literature review. The evidence supports that managing chronic wounds with a multidisciplinary wound care team significantly increases wound healing and reduces the severity of wound-associated pain and the required daily wound treatments compared with persons who are not managed by such a team.\nKeywords: Chronic venous ulceration, chronic venous insufficiency, chronic leg ulcers Abbreviations: VU venous ulceration\nM AN\nUS CR\nIP T\nAC CE\nPT ED"
    }, {
      "heading" : "1. Introduction",
      "text" : "Venous ulceration (VU) is a complex and serious problem that affects 1–2% of the global elderly population (> 65 years), and its incidence is constantly increasing [1]. Varicose veins (VV) without skin changes are present in approximately 25–30% of females and 10– 20% of males in Western countries, and VU represents its most severe clinical manifestation, contributing significantly to the cost of health care [2] . In the United States, venous ulcer treatments have been estimated to cost approximately US $3 billion per year [3]. Vascular disease is very common in Italy, particularly in elderly people living in the southern regions, in whom correlation between arterial sufficiency, VV, and venous incompetence seems to be more pronounced, particularly in men [4]. These lesions have a significant negative impact on patients’ quality of life, because their management is very difficult and are frequently painful and malodourous [5]."
    }, {
      "heading" : "2. Review",
      "text" : ""
    }, {
      "heading" : "2.1 Clinical classification",
      "text" : "There are three different types of chronic leg ulcers: venous, arterial, and mixed. Venous pure insufficiency is the cause of 70–80% of chronic leg ulcers; mixed venous and arterial ulcers account for approximately 15–30% of VU; and arterial pure insufficiency causes 4–7% of chronic leg ulcers.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nPure venous ulcers are the most common type of leg ulcers [6], which have been described since the time of Hippocrates (6). In order to allow uniform diagnosis and comparison of patient populations, in 1994, an international ad hoc committee of American Venous Forum developed a general classification of VU, called CEAP, based on clinical class (C), etiology (E), anatomical distribution (A), and underlying pathophysiology (P). CEAP classification has been reviewed in 2004 with an improvement of underlying details, including terminology; in order to encourage wider use among clinicians, an abbreviated version or “basic” CEAP was adopted as an alternative to the comprehensive version [7, 8]. 2.2 Cause The exact cause of VU in patients with chronic venous insufficiency (CVI) remains unknown; previous studies are focused on the role of macromolecules and inflammation. Several studies emphasized the role of high venous pressure: in 1989, Allman et al. described the following four major etiologic factors involved in the development of venous ulcers: pressure, shearing forces, friction, and moisture [9]. Araki et al. showed that the deficiency of the calf muscle pump is significant with regard to the severity of VU [10]. The base of VU disease is high pressure in an incompetent long saphenous system that, in association with incompetent ankle perforators, gives rise to continuous high venous pressure to fine venous peripheral arches. In fact, venous hypertension leads to extravasation of erythrocytes and macromolecules in the interstitial space using leucocytes (especially macrophages and mast cells) that play a role in cytokine activation. Leucocytes are localized in extracellular matrix around capillaries and postcapillary venules and, in an attempt to maintain vascular architecture in response to increased pressure, they cause a release of inflammatory cytokines that lead to fibrosis and alteration of balance tissue inhibitors of metalloproteases (TIMPS) and metalloproteases (MMP), with retardation of ulcer healing [11]. 2.3 Risk factors\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nSeveral risk factors for chronic venous ulcer have been recognized: older age, family history of VV, and constipation, regardless of sex; obesity and lack of physical activity were more common in women with CVI [12]. Female gender is a risk factor itself, especially with a history of multiple pregnancies even if disparity between the male and female seems to decrease with age. Secondary risks factors are previous injury in legs (deep vein thrombosis (DVT)) and remaining in the standing position for a long time; the effect of prolonged sitting position was not well established. Other VU risk factors such as varicocele and genetic mechanism of heredity, particularly in older age, have been reported in the medical literature [13]. 2.4 Signs and symptoms The most obvious symptoms of VU are swelling, pain in the legs, bleeding, and stasis dermatitis. The pain of VU is severe and bursting, and it intensifies particularly during movements and nighttime. Venous ulcers are usually large, shallow, and rounded lesions, frequently appearing in individuals infected with granulating base and reactive fibrosis. 2.5 Therapy The target of ulcer treatment should always be directed to the cause of the ulcer. The first step in treatment of VU is application of local drugs, bandage, and possible administration of heparin. Treatment modalities are aimed at reducing venous insufficiency; there are three types of noninvasive managements: medical therapy, bandage, and dressings. 2.5.1 Medical therapy: Diuretic therapy is a first-step therapy, but it does not have long-term efficacy. In suprainfected ulcers, there is no evidence to support the routine use of systemic antibiotics in promoting healing of venous leg ulcers. In terms of topical preparations, some evidence supports the use of cadexomer iodine [14].\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nHerbal supplements may reduce the inflammatory response to venous hypertension, but are not licensed by the US Food and Drug Administration, and moreover, they vary in their efficacy, quality, and safety [15].\n2.5.2 Bandage: Leg compression with bandage is fundamental to assist venous return and the bandage is a valid support in VU. It prevents the interface with the ulcers and guarantees the compression of dilated veins. In a recent Cochrane review, there has been some evidence that venous ulcers heal more rapidly with compression than without, and that multicomponent bandage systems achieve better healing results than single-component bandages [16]. The period between bandaging and rebandaging is variable (1–3 days) and depends on the type of VU and patient. The bandage should be a “two-way stretch” type that ensures a crossed compression for reducing edema and support venous blood return. Compression bandaging should be accompanied by encouraging walking and elevation of the legs when sitting. 2.5.3 Dressings: Various dressings contributing to the management of VU are available: hydrocolloids, hydrogels, alginates, foam, and antimicrobial dressing [17,18]. Hydrogel dressing consists of cross-linked insoluble polymers consisting 96% of water. These dressing are used on dry wounds and facilitate autolytic debridement of necrotic tissue. A secondary nonadsorbent dressing is required [19]. Hydrocolloid dressings are occlusive dressings composed of a hydrocolloid matrix bonded onto a vapor-permeable film or foam backing. When in contact with exudate, this dressing forms a gel that facilitates rehydration in ulcers with low to moderate drainage [20]. Foam dressings contain hydrophilic foam and are suitable for all types of exuding wounds. They can be used in combination with other primary dressing. Placed over the ulcer before compression, they promote healing and prevent sticking of bandage on the wound.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nIn fact, there is no evidence supporting the superiority of foam dressings over other dressings in healing. Some evidence shows that they are better than hydrocolloids in handling exudate and easier to remove [21]. Alginates can be used in cavities and complicated lesions. When in contact with exudate, this dressing forms a gel that facilitates rehydration in ulcers with moderate to heavy drainage, promoting autolytic debridement. Calcium ions may aid blood clotting in a bleeding lesion, but this can cause adherence to wound surface. At present, there has been no evidence to suggest any difference in terms of wound healing between different alginate dressings or between alginate dressing and hydrocolloid. Hydrogel is easier to remove than alginate dressing. Further studies are required to show the efficacies of different dressings [22]. Antimicrobial dressing such as the one with ionized silver (Ag+) exhibits both anti-inflammatory and antimicrobial properties with a broad spectrum of action and should be used in selected patients when an infection is suspected [23,24]. The use of silver dressings reduces healing time, thereby resulting in overall cost savings [25]. 2.5.4 New research: In 2014, Serra et al. showed that inhibition of metalloproteinases could represent a possible therapeutic intervention to limit the progression of leg ulceration; in particular, they demonstrated the efficacy of sulodexide in patients with mixed arterial and venous chronic ulcers of the lower limbs [26]."
    }, {
      "heading" : "3. Conclusion",
      "text" : "VU of the legs is a common and significant problem. An accurate physical examination is necessary for a proper diagnosis, but the exact problem is the management. It is very important to know the ulcer’s nature to choose the best type of treatment. Most venous ulcers can be treated with pharmacological medications, but the resolution process is long and weary.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nMany types of dressings are currently used for the treatment of VU. Compressive bandage is fundamental to complete recovery, because it ensures a physiologic venous return, relieves edema, and assists the pumping effects of muscles. Surgical treatment is indicated in venous lesions if they are resistant to medical treatment or in lesions with biopsy positive for cancer. The evidence confirms that managing chronic wounds with a multidisciplinary wound care team significantly improves wound healing and reduces the severity of wound-associated pain and the required daily wound treatments compared with persons who are not managed by such a team.\nM AN\nUS CR\nIP T\nAC CE\nPT ED"
    } ],
    "references" : [ {
      "title" : "Edin- burgh Vein Study",
      "author" : [ "C.J. Evans", "F.G.R. Fowkes", "C.V. Ruckley", "A.J. Lee. Prevalence of varicose veins", "chronic venous insufficiency in men", "women in the general population" ],
      "venue" : "J Epidemiol Community Health. 53",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 1999
    }, {
      "title" : "a randomised controlled trial",
      "author" : [ "R.L. Ashby", "R. Gabe", "S. Ali", "et al. Clinical", "cost effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV", "VenUS IV" ],
      "venue" : "Lancet. 383",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chronic venous disease",
      "author" : [ "J.J. Bergan", "G.W. Schmid-Schönbein", "P.D. Smith", "A.N. Nicolaides", "M.R. Boisseau", "B. Eklof" ],
      "venue" : "N Eng J Med",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2006
    }, {
      "title" : "epidemiology, physiopathology, diagnosis, and treatment",
      "author" : [ "L.P. Abbade", "S. Lastoria. Venous ulcer" ],
      "venue" : "Int J Dermatol. 44",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "the 24-cities cohort study",
      "author" : [ "R. Chiesa", "E.M. Marone", "C. Limoni", "M. Volonté", "E. Schaefer", "O. Petrini. Chronic venous insufficiency in Italy" ],
      "venue" : "Eur J Vasc Endovasc Surg. 30",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Prevalence of leg ulceration in a London population",
      "author" : [ "C.J. Moffatt", "P.J. Franks", "D.C. Doherty", "R. Martin", "R. Blewett", "F. Ross" ],
      "venue" : "QJM",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2004
    }, {
      "title" : "an update",
      "author" : [ "J.M. Porter", "G.L. Moneta. Reporting standards in venous disease" ],
      "venue" : "International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 21",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 1995
    }, {
      "title" : "consensus statement",
      "author" : [ "B. Eklof", "R.B. Rutherford", "J.J. Bergan", "P.H. Carpentier", "P. Glovicski", "R.L. Kistner", "et al. Revision of the CEAP classification for chronic venous disorders" ],
      "venue" : "J Vasc Sur. 40",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Pressure ulcers among the elderly",
      "author" : [ "R.M. Allman" ],
      "venue" : "N Engl J Med",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 1989
    }, {
      "title" : "The significance of calf muscle pump function in venous ulceration",
      "author" : [ "C.T. Araki", "T.L. Back", "F.T. Padberg", "P.N. Thompson", "Z. Jamil", "B.C. Lee" ],
      "venue" : "J Vasc Surg",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 1994
    }, {
      "title" : "Primary chronic venous disorders",
      "author" : [ "Meissner" ],
      "venue" : "J Vasc Surg",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2007
    }, {
      "title" : "The influence of environmental factors in chronic venous insufficiency",
      "author" : [ "A. Jawien" ],
      "venue" : "Angiology",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2003
    }, {
      "title" : "preliminary results of a prospective cohort study",
      "author" : [ "R. Serra", "G. Buffone", "G. Costanzo", "et al. Varicocele in younger as risk factor for inguinal hernia", "for chronic venous disease in older" ],
      "venue" : "Ann Vasc Surg. 27",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Antibiotics and antiseptics for venous leg ulcers",
      "author" : [ "S. O'Meara", "D. Al-Kurdi", "Y. Ologun", "L.G. Ovington", "M. Martyn-St James", "R. Richardson R" ],
      "venue" : "Cochrane Database Syst Rev",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2013
    }, {
      "title" : "Treatment of chronic venous insufficiency",
      "author" : [ "S.W.1 Rathbun", "A.C. Kirkpatrick" ],
      "venue" : "Curr Treat Options Cardiovasc Med",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2007
    }, {
      "title" : "Compression for venous leg ulcers",
      "author" : [ "S. O’Meara", "N. Cullum", "E.A. Nelson", "J.C. Dumville" ],
      "venue" : "Cochrane Database Syst Rev",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2012
    }, {
      "title" : "matching the dressing to the wound",
      "author" : [ "O. Alvarez", "J. Rozint", "D. Wiseman. Moist environment for healing" ],
      "venue" : "Wounds. 1",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 1989
    }, {
      "title" : "Hydrocolloid occlusive dressing management of leg ulcers",
      "author" : [ "S. Freidman", "W.P.D. Su" ],
      "venue" : "Arch Dermatol",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 1984
    }, {
      "title" : "Dressings for healing venous leg ulcers",
      "author" : [ "S.J. Palfreyman", "E.A. Nelson", "R. Lochiel", "J.A. Michaels" ],
      "venue" : "Cochrane Database Syst Rev",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2006
    }, {
      "title" : "Foam dressings for venous leg ulcers",
      "author" : [ "S. O'Meara", "M. Martyn-St James" ],
      "venue" : "Cochrane Database Syst Rev",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2014
    }, {
      "title" : "Alginate dressings for venous leg ulcers",
      "author" : [ "S. O'Meara", "M. Martyn-St James" ],
      "venue" : "Cochrane Database Syst Rev",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2013
    }, {
      "title" : "Silver-Containing Dressings and the Need for Evidence",
      "author" : [ "M.H. Hermans" ],
      "venue" : "Adv Skin Wound Care",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2007
    }, {
      "title" : "their role in wound management",
      "author" : [ "D.J. Leaper. Silver dressings" ],
      "venue" : "Int Wound J. 3",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Cost-Effective Use of Silver Dressings for the Treatment of Hard-to-Heal Chronic Venous Leg Ulcers",
      "author" : [ "G.B. Jemec", "J.C. Kerihuel", "K. Ousey", "S.L. Lauemøller", "D.J. Leaper" ],
      "venue" : "PLoS One",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2014
    }, {
      "title" : "The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs",
      "author" : [ "R. Serra", "L. Gallelli", "A. Conti", "G. De Caridi", "M. Massara", "F. Spinelli", "G. Buffone", "F.G. Caliò", "B. Amato", "S. Ceglia", "G. Spaziano", "L. Scaramuzzino", "A.G. Ferrarese", "R. Grande", "S. De Franciscis" ],
      "venue" : "Drug Des Devel Ther",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2014
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Introduction Venous ulceration (VU) is a complex and serious problem that affects 1–2% of the global elderly population (> 65 years), and its incidence is constantly increasing [1].",
      "startOffset" : 177,
      "endOffset" : 180
    }, {
      "referenceID" : 1,
      "context" : "Varicose veins (VV) without skin changes are present in approximately 25–30% of females and 10– 20% of males in Western countries, and VU represents its most severe clinical manifestation, contributing significantly to the cost of health care [2] .",
      "startOffset" : 243,
      "endOffset" : 246
    }, {
      "referenceID" : 2,
      "context" : "In the United States, venous ulcer treatments have been estimated to cost approximately US $3 billion per year [3].",
      "startOffset" : 111,
      "endOffset" : 114
    }, {
      "referenceID" : 3,
      "context" : "Vascular disease is very common in Italy, particularly in elderly people living in the southern regions, in whom correlation between arterial sufficiency, VV, and venous incompetence seems to be more pronounced, particularly in men [4].",
      "startOffset" : 232,
      "endOffset" : 235
    }, {
      "referenceID" : 4,
      "context" : "These lesions have a significant negative impact on patients’ quality of life, because their management is very difficult and are frequently painful and malodourous [5].",
      "startOffset" : 165,
      "endOffset" : 168
    }, {
      "referenceID" : 5,
      "context" : "5 Pure venous ulcers are the most common type of leg ulcers [6], which have been described since the time of Hippocrates (6).",
      "startOffset" : 60,
      "endOffset" : 63
    }, {
      "referenceID" : 6,
      "context" : "CEAP classification has been reviewed in 2004 with an improvement of underlying details, including terminology; in order to encourage wider use among clinicians, an abbreviated version or “basic” CEAP was adopted as an alternative to the comprehensive version [7, 8].",
      "startOffset" : 260,
      "endOffset" : 266
    }, {
      "referenceID" : 7,
      "context" : "CEAP classification has been reviewed in 2004 with an improvement of underlying details, including terminology; in order to encourage wider use among clinicians, an abbreviated version or “basic” CEAP was adopted as an alternative to the comprehensive version [7, 8].",
      "startOffset" : 260,
      "endOffset" : 266
    }, {
      "referenceID" : 8,
      "context" : "described the following four major etiologic factors involved in the development of venous ulcers: pressure, shearing forces, friction, and moisture [9].",
      "startOffset" : 149,
      "endOffset" : 152
    }, {
      "referenceID" : 9,
      "context" : "showed that the deficiency of the calf muscle pump is significant with regard to the severity of VU [10].",
      "startOffset" : 100,
      "endOffset" : 104
    }, {
      "referenceID" : 10,
      "context" : "of balance tissue inhibitors of metalloproteases (TIMPS) and metalloproteases (MMP), with retardation of ulcer healing [11].",
      "startOffset" : 119,
      "endOffset" : 123
    }, {
      "referenceID" : 11,
      "context" : "6 Several risk factors for chronic venous ulcer have been recognized: older age, family history of VV, and constipation, regardless of sex; obesity and lack of physical activity were more common in women with CVI [12].",
      "startOffset" : 213,
      "endOffset" : 217
    }, {
      "referenceID" : 12,
      "context" : "Other VU risk factors such as varicocele and genetic mechanism of heredity, particularly in older age, have been reported in the medical literature [13].",
      "startOffset" : 148,
      "endOffset" : 152
    }, {
      "referenceID" : 13,
      "context" : "In terms of topical preparations, some evidence supports the use of cadexomer iodine [14].",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 14,
      "context" : "7 Herbal supplements may reduce the inflammatory response to venous hypertension, but are not licensed by the US Food and Drug Administration, and moreover, they vary in their efficacy, quality, and safety [15].",
      "startOffset" : 206,
      "endOffset" : 210
    }, {
      "referenceID" : 15,
      "context" : "In a recent Cochrane review, there has been some evidence that venous ulcers heal more rapidly with compression than without, and that multicomponent bandage systems achieve better healing results than single-component bandages [16].",
      "startOffset" : 228,
      "endOffset" : 232
    }, {
      "referenceID" : 16,
      "context" : "3 Dressings: Various dressings contributing to the management of VU are available: hydrocolloids, hydrogels, alginates, foam, and antimicrobial dressing [17,18].",
      "startOffset" : 153,
      "endOffset" : 160
    }, {
      "referenceID" : 17,
      "context" : "3 Dressings: Various dressings contributing to the management of VU are available: hydrocolloids, hydrogels, alginates, foam, and antimicrobial dressing [17,18].",
      "startOffset" : 153,
      "endOffset" : 160
    }, {
      "referenceID" : 18,
      "context" : "When in contact with exudate, this dressing forms a gel that facilitates rehydration in ulcers with low to moderate drainage [20].",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 19,
      "context" : "Some evidence shows that they are better than hydrocolloids in handling exudate and easier to remove [21].",
      "startOffset" : 101,
      "endOffset" : 105
    }, {
      "referenceID" : 20,
      "context" : "Further studies are required to show the efficacies of different dressings [22].",
      "startOffset" : 75,
      "endOffset" : 79
    }, {
      "referenceID" : 21,
      "context" : "Antimicrobial dressing such as the one with ionized silver (Ag) exhibits both anti-inflammatory and antimicrobial properties with a broad spectrum of action and should be used in selected patients when an infection is suspected [23,24].",
      "startOffset" : 228,
      "endOffset" : 235
    }, {
      "referenceID" : 22,
      "context" : "Antimicrobial dressing such as the one with ionized silver (Ag) exhibits both anti-inflammatory and antimicrobial properties with a broad spectrum of action and should be used in selected patients when an infection is suspected [23,24].",
      "startOffset" : 228,
      "endOffset" : 235
    }, {
      "referenceID" : 23,
      "context" : "The use of silver dressings reduces healing time, thereby resulting in overall cost savings [25].",
      "startOffset" : 92,
      "endOffset" : 96
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}